U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.
Full record GDS4336

Pancreatic ductal adenocarcinoma tumor and adjacent non-tumor tissue

Analysis of 45 matching pairs of pancreatic ductal adenocarcinoma (PDAC) tumor and adjacent non-tumor tissue. Results provide insight into tumor markers with prognostic significance and molecular mechanisms underlying PDAC.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 3 disease state, 45 individual, 2 tissue sets
Platform:
GPL6244
Series:
GSE28735
90 Samples
Download data: CEL
2.

Microarray gene-expression profiles of 45 matching pairs of pancreatic tumor and adjacent non-tumor tissues from 45 patients with pancreatic ductal adenocarcinoma

(Submitter supplied) In order to identify biologically relevant tumor markers with prognostic significance, we set out to analyze gene expression profiling of tumor and adjacent non-tumor tissues from PDAC cases. We compared the microarray gene-expression profiles of 45 matching pairs of pancreatic tumor and adjacent non-tumor tissues. This data set were used to obtained genes that were differentially expressed and associated with survival. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4336
Platform:
GPL6244
90 Samples
Download data: CEL
Series
Accession:
GSE28735
ID:
200028735
3.

Global mRNA/LncRNA expression analysis of pancreatic tumors causing type3C Diabetes Mellitus

(Submitter supplied) Pancreatic tumors with small size can cause type3C Diabetes Mellitus (PCA-DM) but the mechanism is unknown. In this study we aimed at revealing the mRNA and long noncoding RNA (LncRNA) expression patterns of pancreatic tumors that triggered PCA-DM. Four pancreatic tumors from patients with PCA-DM (A1-A4), four pancreatic tumors from patients without PCA-DM (B1-B4), and four pancreatic tissues from patients with pancreatitis were individually profiled with Agilent microarrays(Arraystar Human LncRNA Array v3.0).
Organism:
Homo sapiens
Type:
Expression profiling by array; Non-coding RNA profiling by array
Platform:
GPL16956
12 Samples
Download data: TXT
Series
Accession:
GSE61166
ID:
200061166
4.

Microarray gene-expression profiles of 50 pancreatic tumors tissue from patients with pancreatic ductal adenocarcinoma

(Submitter supplied) In order to identify biologically relevant tumor markers, and novel therapeutic target we have compared the tumor gene expression profiles of long (OS>=24 months,n=14) and short (OS <=7months, n=11) survival patients. Then we conducted Kaplan-Meier survival analysis using all the 50 samples listed here. The Affymetrix gene-expression data of these 50 samples were also included in the earlier submission by us as GEO accession number GSE62452.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6244
50 Samples
Download data: CEL
Series
Accession:
GSE78229
ID:
200078229
5.

microRNA Expression profiles of parental Panc1 cell lines and Gemcitabine resistance Panc1 cell lines

(Submitter supplied) Gemcitabine (GEM) is a key drug for treating PDAC, and it is commonly used for adjuvant chemotherapy. Although the majority of PDAC is sensitive to GEM at first, GEM cannot control PDAC for very long, suggesting that PDAC develops resistance to GEM after prolonged exposure. No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic ductal adenocarcinoma. MicroRNAs (miR) are epigenetic gene regulators with tumorsuppressive or oncogenic roles in various carcinomas. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL15446
4 Samples
Download data: TXT
Series
Accession:
GSE80616
ID:
200080616
6.

microRNA Expression Profiling of MIF-high and MIF-low Pancreatic Ductal Adenocarcinoma using Nanostring nCounter Platform

(Submitter supplied) We identified differentially expressed microRNAs between MIF-high and MIF-low tumor groups. These microRNAs were then investigated for their potential downstream targets using an integrative strategy, which combines miR-Walk target prediction module and mRNA expression array data to identify key MIF-induced signalling pathways driving tumor progresion and disease aggressiveness. Genes that associated with prognostic significance was then subjected to mechanistic study.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL16142
69 Samples
Download data: RCC, TXT
Series
Accession:
GSE62498
ID:
200062498
7.

Microarray gene-expression profiles of 69 pancreatic tumors and 61 adjacent non-tumor tissue from patients with pancreatic ductal adenocarcinoma

(Submitter supplied) In order to identify biologically relevant tumor markers , we analyzed gene expression profiling of tumor and adjacent non-tumor tissues from PDAC cases. We compared the microarray gene-expression profiles of MIF-high and MIF low expressing tumors as detrmined by qRT-PCR. Affymetrix gene-expression analysis was done in two sets. Affymetrix data from sample number 1-90 were earlier submited by us as GEO accession#: GSE28735. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6244
130 Samples
Download data: CEL, XLSX
Series
Accession:
GSE62452
ID:
200062452
8.

Expression data from gemcitabine treated pancreatic CAFs

(Submitter supplied) Pancreatic ductal adenocarcinoma (PDAC) has a characteristically dense stroma comprised predominantly of cancer associated fibroblasts (CAFs). CAFs promote tumor growth, metastasis and treatment resistance. We aimed to investigate the molecular changes and functional consequences associated with chemotherapy treatment of PDAC CAFs. Chemoresistant immortalized CAFs (R-CAFs) were generated by continuous incubation in 100nM gemcitabine. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
4 Samples
Download data: CEL, CHP
Series
Accession:
GSE78982
ID:
200078982
9.

Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
Platforms:
GPL24676 GPL18573
39 Samples
Download data
Series
Accession:
GSE158541
ID:
200158541
10.

Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition [ChIP-seq]

(Submitter supplied) We performed ChIP-seq ananlysis on HDAC1 in MiaPaCa2 using two different antibodies (Santa Cruz Biotechnologies sc-81598 HDAC1(10E2) and Invitrogen HDAC1 Polyclonal Antibody PA1-860), two non-targeting scrableled sgRNA controls and two replicates for each.
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL24676
10 Samples
Download data: BED
Series
Accession:
GSE158540
ID:
200158540
11.

Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition [RNA-Seq]

(Submitter supplied) Over expression of co-repressor complexes implicated as a cause of multiple drug resistance in pancreatic cancer.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18573
29 Samples
Download data: CSV
12.

RNA-sequencing of Panc-1 cells with ABCG2 over-expression

(Submitter supplied) The goal of this study was to determine whether the selected sgRNAs increases expression of ABCG2 and whether there are other significant off-target effects
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
4 Samples
Download data: XLSX
13.

A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma

(Submitter supplied) A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma Pancreatic ductal adenocarcinoma (PDAC), comprising over 90% of all pancreatic cancers, remains a lethal disease with an estimated 232,000 new cases, 227,000 deaths per year worldwide, and a less than 5% five-year survival rate. Currently the standard of care for the 20% of patients with localized disease is surgery followed by chemotherapy, and in some cases radiation. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL4133
132 Samples
Download data
Series
Accession:
GSE21501
ID:
200021501
14.

microRNA screening in human pancreatic adenocarcinoma

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens; synthetic construct
Type:
Non-coding RNA profiling by array
Platforms:
GPL14613 GPL16384
20 Samples
Download data: CEL
Series
Accession:
GSE74574
ID:
200074574
15.

MicroRNA screening in human pancreatic carcinoma cell lines

(Submitter supplied) No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic ductal adenocarcinoma. MicroRNAs (miR) are epigenetic gene regulators with tumorsuppressive or oncogenic roles in various carcinomas. This study assesses chemoresistant PDAC for its specific miR expression pattern. Gemcitabine-resistant variants of two mutant p53 human pancreatic adenocarcinoma cell lines were established. more...
Organism:
Homo sapiens; synthetic construct
Type:
Non-coding RNA profiling by array
Platform:
GPL16384
12 Samples
Download data: CEL
Series
Accession:
GSE74565
ID:
200074565
16.

In vitro microRNA screening in human pancreatic adenocarcinoma

(Submitter supplied) No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic ductal adenocarcinoma. MicroRNAs (miR) are epigenetic gene regulators with tumorsuppressive or oncogenic roles in various carcinomas. This study assesses chemoresistant PDAC for its specific miR expression pattern. Gemcitabine-resistant variants of PANC-1, a mutant p53 human pancreatic adenocarcinoma cell line, were established. more...
Organism:
Homo sapiens; synthetic construct
Type:
Non-coding RNA profiling by array
Platform:
GPL14613
8 Samples
Download data: CEL
Series
Accession:
GSE74562
ID:
200074562
17.

High-throughput microRNA (miRNAs) arrays in pancreatic cancer

(Submitter supplied) Background: Only a subset of radically-resected pancreatic ductal adenocarcinoma (PDAC) patients benefit from chemotherapy, and identification of novel prognostic factors is warranted. Recently miRNAs emerged as diagnostic biomarkers and innovative therapeutic targets, while high-throughput arrays are opening new opportunities to evaluate whether they can also predict clinical outcome. The present study evaluated whether comprehensive miRNA expression profiling correlated with overall survival (OS) in resected PDAC patients. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL14903
19 Samples
Download data: TXT
Series
Accession:
GSE38781
ID:
200038781
18.

Gene expression analysis of pancreatic cancer associated fibroblasts

(Submitter supplied) Gene expression analysis of pancreatic cancer associated fibroblasts and control fibroblasts To identify signaling pathways important in tumor-stromal cell interactions, we performed gene expression profiling on pancreatic cancer associated fibroblast cultures and control fibroblast cultures using Affymetrix Exon arrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5188
12 Samples
Download data: CEL
Series
Accession:
GSE21440
ID:
200021440
19.

Targeting multiple effector pathways in pancreatic ductal adenocarcinoma with a G-quadruplex-binding small molecule

(Submitter supplied) Human pancreatic ductal adenocarcinoma (PDAC) involves the dysregulation of multiple signalling pathways. A novel approach to the treatment of PDAC is described, involving the targeting of cancer genes in PDAC pathways having over-representation of G-quadruplexes, using the quadruplex-binding compound CM03. This has been designed by computer modelling, is a potent inhibitor of cell growth in PDAC cell lines and has anti-cancer activity in PDAC models, with a superior profile compared to gemcitabine, a commonly used therapy. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18573
104 Samples
Download data: TXT
20.

PRMT1 Promotes Epigenetic Reprogramming Associated with Acquired Chemoresistance in Pancreatic Cancer

(Submitter supplied) Pancreatic Ductal Adenocarcinoma (PDAC) is associated with extremely poor prognosis due to late diagnosis and therapeutic resistance. Here we show that PDAC cells undergo progressive reprogramming of the global epigenetic landscape during the process of acquiring chemoresistance. Through an epigenetic inhibitor screen, we identified Protein Arginine methyltransferase 1 (PRMT1) as a central driver of chemoresistance in PDAC. more...
Organism:
Mus musculus
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL24247
29 Samples
Download data: BW
Series
Accession:
GSE227129
ID:
200227129
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=6|qty=4|blobid=MCID_67277e67d916f0096868eeae|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center